[go: up one dir, main page]

FR2383929A1 - 1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees - Google Patents

1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees

Info

Publication number
FR2383929A1
FR2383929A1 FR7820342A FR7820342A FR2383929A1 FR 2383929 A1 FR2383929 A1 FR 2383929A1 FR 7820342 A FR7820342 A FR 7820342A FR 7820342 A FR7820342 A FR 7820342A FR 2383929 A1 FR2383929 A1 FR 2383929A1
Authority
FR
France
Prior art keywords
benzazepines
tetrahydro
hydroxy
substituted
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7820342A
Other languages
English (en)
Other versions
FR2383929B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of FR2383929A1 publication Critical patent/FR2383929A1/fr
Application granted granted Critical
Publication of FR2383929B1 publication Critical patent/FR2383929B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention a pour objet des composés de formule :
FR7820342A 1977-02-02 1978-07-07 1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees Granted FR2383929A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,672 US4111957A (en) 1977-02-02 1977-02-02 Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Publications (2)

Publication Number Publication Date
FR2383929A1 true FR2383929A1 (fr) 1978-10-13
FR2383929B1 FR2383929B1 (fr) 1981-07-31

Family

ID=25071413

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7802275A Granted FR2379534A1 (fr) 1977-02-02 1978-01-27 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees
FR7820342A Granted FR2383929A1 (fr) 1977-02-02 1978-07-07 1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7802275A Granted FR2379534A1 (fr) 1977-02-02 1978-01-27 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees

Country Status (6)

Country Link
US (1) US4111957A (fr)
JP (2) JPS5395989A (fr)
BE (1) BE868868A (fr)
DE (1) DE2804285A1 (fr)
FR (2) FR2379534A1 (fr)
GB (1) GB1599705A (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352754A (en) * 1976-11-17 1982-10-05 Smithkline Corporation 3-Thienylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
ZA792785B (en) * 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
US4282146A (en) * 1978-11-20 1981-08-04 Pennwalt Corporation Preparation of 1,2,4,5-tetrahydro-7-alkoxy-(and 7,8-dialkoxy)-3H,3-benzazepines and 3-substituted derivatives thereof from the corresponding phenethylamines
US4255445A (en) * 1980-03-07 1981-03-10 Smithkline Corporation 8-Hydroxy-6,7-(2-methyl-2,3-dihydrofuro)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
US4769368A (en) * 1986-02-10 1988-09-06 Smithkline Beckman Corporation 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
JPH03153111A (ja) * 1989-11-09 1991-07-01 Murata Mfg Co Ltd 弾性表面波発振器
GB9903671D0 (en) * 1999-02-17 1999-04-14 Cenes Ltd Dopamine D-1 receptor agonist compounds
US6953787B2 (en) * 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EP2332921B1 (fr) 2003-06-17 2016-03-02 Arena Pharmaceuticals, Inc. 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride
CN1805938B (zh) * 2003-06-17 2010-06-16 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
WO2005042491A1 (fr) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Derives de benzazepine et methodes de prophylaxie ou traitement de maladies associees au recepteur 5ht2c
WO2005042490A1 (fr) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Derives de benzazepine et methodes de prophylaxie ou de traitement de maladies associees au recepteur 5-ht2c
NZ589756A (en) 2004-12-21 2012-05-25 Arena Pharm Inc Method for the preparation of crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
WO2006071740A2 (fr) 2004-12-23 2006-07-06 Arena Pharmaceuticals, Inc. Compositions renfermant un modulateur des recepteurs 5ht2c et procedes d'utilisation correspondants
CN101466684B (zh) 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
CA2670285A1 (fr) * 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Procedes de preparation de (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine et intermediaires de celle-ci
JP4933325B2 (ja) * 2007-03-29 2012-05-16 原田工業株式会社 接続端子構造
EP2288585A1 (fr) * 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Procédés de préparation d'intermédiaires se rapportant à l'agoniste 5-ht2c (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazepine
EP2443080A2 (fr) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Procédés pour la préparation d'agonistes du récepteur 5-ht<sb>2c</sb>
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2012030939A1 (fr) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Administration de lorcasérine à des individus présentant une insuffisance rénale
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
EP2611433A2 (fr) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Sels non hygroscopiques d'agonistes de 5-ht2c
EP3485878A1 (fr) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Formes posologiques à libération modifiée d'agonistes de 5-ht2c utiles pour la gestion du poids
JP2015534563A (ja) 2012-10-09 2015-12-03 アリーナ ファーマシューティカルズ， インコーポレイテッド 体重管理の方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US3663532A (en) * 1970-03-04 1972-05-16 American Home Prod Benzodiazocines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV875/66 *

Also Published As

Publication number Publication date
GB1599705A (en) 1981-10-07
FR2379534B1 (fr) 1981-11-27
JPS5395989A (en) 1978-08-22
BE868868A (fr) 1979-01-10
DE2804285C2 (fr) 1988-01-07
US4111957A (en) 1978-09-05
FR2383929B1 (fr) 1981-07-31
JPS62161764A (ja) 1987-07-17
DE2804285A1 (de) 1978-08-03
JPS6341912B2 (fr) 1988-08-19
FR2379534A1 (fr) 1978-09-01

Similar Documents

Publication Publication Date Title
FR2383929A1 (fr) 1-hydroxy 2, 3, 4, 5-tetrahydro-1h-3-benzazepines substituees
FR2392671A1 (fr) Application pharmacologique des acides d2-3-1,4-morpholine-2-carboxyliques substitues
FR2453145A1 (fr)
FR2374315A1 (fr) Derives de morpholine utilisables comme fongicides
FR2389605A1 (fr)
FR2371434A1 (fr) Derives triazoliques utiles comme fongicides
FR2362170A1 (fr) Nouvelles polyurees
FR2392013A1 (fr) Ethers d&#39;azolyl-acetophenonoxime utiles comme fongicides
FR2372165A1 (fr)
FR2361376A1 (fr) Nouveaux tetrazoles
FR2360583A1 (fr) B-azolylcetones utiles comme fongicides
FR2389608A1 (fr)
FR2366276A1 (fr) Aza-13 prostaglandines
FR2361351A1 (fr) Intermediaires de preparation d&#39;homologues de somatostatine
FR2369276A1 (fr) Nouve
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
FR2384759A1 (fr) 1-phenyl-2,3,4,5 tetrahydro-1h benzazepine-7,8-diones
FR2422641A1 (fr) 7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines
FR2389615A1 (fr)
FR2373535A1 (fr)
FR2446284A1 (fr) Tetrahydro-benzo(c)quinoleine-9(8h)ones
FR2382431A1 (fr) Nouvelles 2-hydroxy-propylamines, leur preparation et leur utilisation comme agents tensio-actifs
FR2398752A1 (fr) Esters tetracarboxyliques de 2,2,6,6-tetramethyl-piperidino-spiro-dioxanol
FR2355840A1 (fr) Nouveaux derives de l&#39;oxadiazole-5-thiol
FR2415619A1 (fr) 3-chloro-2,6-dinitro-n-(phenyl substitue)-4-(trifluoromethyl) benzenamines fongicides

Legal Events

Date Code Title Description
ST Notification of lapse